Literature DB >> 25763931

NFκB and Survivin-Mediated Radio-Adaptive Response.

David J Grdina1, Jeffrey S Murley, Richard C Miller, Gayle E Woloschak, Jian Jian Li.   

Abstract

A survivin-mediated radio-adaptive response was induced in SA-NH murine sarcoma cells following activation of nuclear transcription factor κB (NFκB) by very low doses of ionizing radiation of 5, 20 or 100 mGy. SA-NH cells and a clone stably transfected with a plasmid containing a mutated IκBα gene that prevents the activation of NFκB (SA-NH+mIκBα1) were used to investigate the role of NFκB activation in the development and expression of the survivin-mediated radio-adaptive response. Tumor cells were exposed to very low doses of radiation 30 min prior to or at times ranging from 30 min to 6 h after the first of two 2 Gy doses separated by 24 h under in vitro conditions. Evidence of very low dose radiation induced a radio-adaptive response only in SA-NH but not SA-NH+mIκBα1 cells was shown by both an increase in SA-NH cell survival of 20-40% using a standard colony forming assay and reduced apoptosis frequencies of 20-40% as determined by the TUNEL assay. Changes in survivin protein levels as a function of irradiation conditions were monitored by Western blot. A 100 mGy exposure 30 min prior to a 2 Gy dose resulted in an elevation in total survivin protein 24 h later in SA-NH but not SA-NH+mIκBα1 cells. Transfection of cells with survivin siRNA inhibited elevation of survivin protein by very low dose radiation and the subsequent radio-adaptive response in SA-NH cells. These data suggest that the survivin-mediated radio-adaptive response is dependent upon the ability of cells to activate NFκB.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25763931     DOI: 10.1667/RR14002.1

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  4 in total

1.  TP53 Mutational Status and ROS Effect the Expression of the Survivin-Associated Radio-Adaptive Response.

Authors:  Jeffrey S Murley; Richard C Miller; Ralph R Weichselbaum; David J Grdina
Journal:  Radiat Res       Date:  2017-08-16       Impact factor: 2.841

2.  Very low doses of ionizing radiation and redox associated modifiers affect survivin-associated changes in radiation sensitivity.

Authors:  Richard C Miller; Jeffrey S Murley; Alfred W Rademaker; Gayle E Woloschak; Jian Jian Li; Ralph R Weichselbaum; David J Grdina
Journal:  Free Radic Biol Med       Date:  2016-07-15       Impact factor: 7.376

3.  Exploiting DNA repair pathways for tumor sensitization, mitigation of resistance, and normal tissue protection in radiotherapy.

Authors:  Jac A Nickoloff; Lynn Taylor; Neelam Sharma; Takamitsu A Kato
Journal:  Cancer Drug Resist       Date:  2021-06-19

Review 4.  Therapeutic Implications for Overcoming Radiation Resistance in Cancer Therapy.

Authors:  Byeong Mo Kim; Yunkyung Hong; Seunghoon Lee; Pengda Liu; Ji Hong Lim; Yong Heon Lee; Tae Ho Lee; Kyu Tae Chang; Yonggeun Hong
Journal:  Int J Mol Sci       Date:  2015-11-10       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.